Tag:
Scientific Protein Laboratories
Latest Headlines
Latest Headlines
SPL's heparin response earns FDA warning
Heparin makes its way back into the news in an FDA warning letter to API maker Scientific Protein Labs. The letter addressed to CEO David Strunce is dated Jan. 20 and refers to a Waunakee, WI, plant
FDA scolds SPL in manufacturing warning
The FDA has issued a warning letter to Scientific Protein Laboratories, one of the companies at the center of the heparin scandal in 2008, raising several questions about its handling of the drug.
Judge rules against Baxter in heparin case
Statements by Baxter ( $BAX ) executives about defective heparin played a key role in a judge's ruling against the company in a case concerning more than 80 U.S. deaths involving the contaminated blood
Heparin recall again traced to API supplier SPL
Heparin has earned special notice in pharma manufacturing circles for the devastating case of contamination that killed or sickened dozens of people in the U.S. in 2008. B. Braun Medical is
FDA probes SPL over contaminated heparin
The FDA is still investigating Scientific Protein Laboratories over a case of contaminated heparin that occurred after the headline-grabbing Baxter recall of the blood thinner in 2008. The initially
